Marconi Abreu, M.D.

Marconi Abreu, M.D., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Endocrinology. 

Originally from Salvador, Brazil, Dr. Abreu earned his medical degree at Universidade Federal da Bahia in the State of Bahia, Brazil. He completed internal medicine residency training at the University of Connecticut in Mansfield, Connecticut, where he was Chief Resident. He then completed advanced training through a fellowship in endocrinology at UT Southwestern Medical Center.

Certified by the American Board of Internal Medicine in endocrinology, Dr. Abreu joined the UT Southwestern faculty in 2015. Dr. Abreu enjoys helping patients meet their goals by empowering them to be in the “driver’s seat” of their care.

At UT Southwestern, Dr. Abreu is on the Compliance and Billing Committee, as well as the UT Southwestern Diabetes Advisory Board.

Dr. Abreu is a member of the American Diabetes Association and has been an intermittent member of the American Association of Clinical Endocrinologists and the Endocrinology Society.

Outside of medicine, Dr. Abreu likes to cook, travel, and play the guitar.

Medical School

Universidade Federal Do Bahia (2002)

Residency

University of Connecticut Health Center (2008), Internal Medicine

Chief Resident

University of Connecticut Health Center (2008), Internal Medicine

Fellowship

UT Southwestern Medical Center (2015), Endocrinology & Metabolism

• Reproductive Endocrinology
• Type-2 Diabetes

Featured Publications

VISUAL VIGNETTE.

Patel SM, Marconi A, Gunasekaran U, Lingvay I, Endocr Pract 2019 Jul 25 7 771

A randomized trial comparing the efficacy and safety of treating patients with very elevated hba1c levels with basal-bolus insulin or a glp-1 receptor agonist plus basal insulin: The simple study.

Abreu M, Tumyan A, Elhassan A, Peicher K, Papacostea O, Dimachkie P, Siddiqui MS, Pop LM, Gunasekaran U, Meneghini LF, Adams-Huet B, Li X, Lingvay I, Diabetes Obes Metab 2019 May

DETERMINING INSULIN DOSE AT THE TIME OF DISCHARGE IN A HIGH-RISK POPULATION: IS THERE ROOM FOR IMPROVEMENT?

Carruthers D, Ismaily M, Vanderheiden A, Yates M, DeGueme A, Adams-Huet B, Basani S, Abreu M, Lingvay I, Endocr Pract 2019 Mar 25 3 263-269

Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study.

Patel S, Abreu M, Tumyan A, Adams-Huet B, Li X, Lingvay I, BMJ Open Diabetes Res Care 2019 7 1 e000761

SGLT2 inhibition and heart failure-current concepts.

Custodio JS, Duraes AR, Abreu M, Albuquerque Rocha N, Roever L Heart Fail Rev 2018 Apr

Implementation of a systematic approach to diabetes in primary care in Bahia, Brazil improves metabolic outcomes: PRODIBA-Programa de Interiorizacao da Assistencia ao Diabetes na Bahia (Project for Dissemination of Diabetes Care in the State of Bahia).

Chaves-Fonseca RM, Matos OS, Lordelo RA, Abreu M, Farias MG, Coutinho JF, Ribeiro MN, Matteoni-Athayde L, Lessa I, Pousada J, Oliveira M, Lopes C, Strock E, Mazze R Diabet. Med. 2009 Mar 26 3 286-92

• Daniel W. Foster, MD Award for Excellence in Clinical Training
  UT Southwestern (2016)
• Exceptional Contributor to the Brazilian Community of Taunton, MA
  (2010)
• Pamela Kisluk Spirit Award
  University of Connecticut (2007)

• American Association of Clinical Endocrinologists (2014)
• The Endocrine Society (2013)
• American Diabetes Association (2004)